Bacanlı, Ali
Unsel-Bolat, Gul http://orcid.org/0000-0002-4574-421X
Suren, Serkan
Yazıcı, Kemal Utku
Callı, Cem
Aygunes Jafari, Duygu
Kosova, Buket
Rohde, Luis Augusto
Ercan, Eyup Sabri
Funding for this research was provided by:
Ege University Scientific Research Project Commission, Izmir, Turkey (-)
The National Council for Scientific and Technological Development (CNPq, Brazil), and Hospital de Clinicas de Porto Alegre (HCPA), Porto Alegre, Brazil (-)
Article History
Accepted: 20 December 2020
First Online: 20 January 2021
Compliance with ethical standards
: After the study procedures were described, the participants’ parents provided written informed consent. The Ethics Committee of Ege University in Turkey approved the study protocol.
: Eyüp Sabri Ercan is on the advisory board of Sanofi Turkey. L. A. Rohde received grant or research support and served as a consultant and on the speakers’ bureaus of Eli Lilly and Co., Janssen, Medice, Novartis and Shire. The ADHD and Juvenile Bipolar Disorder Outpatient Programs chaired by Dr. Rohde received unrestricted educational and research support from the following pharmaceutical companies: Janssen, Novartis, and Shire. Dr. Rohde received travel grants from Shire to participate in the 2015 WFADHD congress. He received royalties from Artmed Editora and Oxford University Press. The other authors declare that they have no conflicts of interest to report.